scispace - formally typeset
J

Jane Fridlyand

Researcher at Genentech

Publications -  74
Citations -  19991

Jane Fridlyand is an academic researcher from Genentech. The author has contributed to research in topics: Comparative genomic hybridization & Gene. The author has an hindex of 47, co-authored 73 publications receiving 19127 citations. Previous affiliations of Jane Fridlyand include Royal Melbourne Hospital & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Shaping of tumor and drug-resistant genomes by instability and selection.

TL;DR: The concept that tumor genomes are shaped by selection for alterations that promote survival and growth advantage, as well as by the particular dysfunctions in genes responsible for maintenance of genetic integrity, is supported.
Journal ArticleDOI

Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer.

TL;DR: The data suggests that patients with NNBC with the 11q deletion might benefit from anthracycline-based chemotherapy despite other clinical, pathologic, or genetic features, however, these initial findings should be evaluated in randomized clinical trials.
Journal ArticleDOI

Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach

TL;DR: In this paper, the authors used array-based comparative genomic hybridization (CGH) to study genetic imbalances in 39 Angioimmunoblastic T-cell lymphoma (AILT) and 20 PTCL-u.
Journal ArticleDOI

Mapping segmental and sequence variations among laboratory mice using BAC array CGH.

TL;DR: It is shown that small ratio changes distinguish homozygous and heterozygous regions of the genome in interspecific backcross mice, providing an efficient method for genotyping progeny of backcrosses.